Flagship explainer
What drives NEOGENOMICS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$108M | FY2025 |
| |
| Income before tax | −$110M | FY2025 |
|
| Operating income | −$116M | FY2025 |
|
| $727M | FY2025 |
| |
| Ending assets | $1.4B | FY2025 |
|
| Beginning assets | $1.6B | FY2024 |
|
| $837M | FY2025 |
| |
| $902M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001077183-26-000010